World's Best Scientists 2026 revealed!
VIEW LIST
Myung-Ju Ahn
Award Badge
Best Female Scientists
2025
Award Badge
Medicine
Korea
2026

D-Index & Metrics

Best Female Scientists

D-Index
108
Citations
67476
World Ranking
955
National Ranking
1

Medicine

D-Index
113
Citations
72723
World Ranking
4832
National Ranking
6

Myung-Ju Ahn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Myung-Ju Ahn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 728 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Myung-Ju Ahn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Myung-Ju Ahn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Korea Leader Award
  • 2025 - Research.com Best Female Scientists Award
  • 2025 - Research.com Medicine in Korea Leader Award

Overview

Myung-Ju Ahn is affiliated with Sungkyunkwan University in South Korea and has contributed extensively to the field of medicine, focusing primarily on pulmonary and respiratory medicine as well as oncology. Their research encompasses molecular biology, cancer research, and radiology, nuclear medicine, and imaging, with a particular emphasis on lung cancer treatments and mutations.

The scientist's main topics of work include:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Radiomics and Machine Learning in Medical Imaging

Significant papers co-authored in recent years include:

  • "Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma," 2020, Nature Communications
  • "Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer," 2020, JAMA Oncology
  • "TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer," 2020, Annals of Oncology
  • "Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study," 2020, The Lancet Oncology
  • "Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial," 2020, Journal of Clinical Oncology

Frequent co-authors in their publications are:

  • Se-Hoon Lee
  • Hyun Ae Jung
  • Jin Seok Ahn
  • Jong-Mu Sun
  • Keunchil Park

Publications by Myung-Ju Ahn have appeared repeatedly in the following venues:

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Cancer Research
  • Cancer Research and Treatment
  • Annals of Oncology

Their scholarly output totals over 900 publications primarily in medicine, with focused research advancing understanding and treatments related to lung cancer and cancer immunotherapy. The integration of molecular biology and radiology techniques is also evident throughout their work, highlighting interdisciplinary approaches in cancer diagnostics and personalized therapies.

Best Publications

  • Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

    Roy S. Herbst;Paul Baas;Dong Wan Kim;Enriqueta Felip

  • Pembrolizumab for the treatment of non-small cell lung cancer

    Edward B. Garon;Naiyer A. Rizvi;Rina Hui;Natasha Leighl

  • Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

    Alice T. Shaw;Dong Wan Kim;Kazuhiko Nakagawa;Takashi Seto

  • Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

    Tony S. Mok;Yi Long Wu;Myung Ju Ahn;Marina C. Garassino

  • Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

    Tony S.K. Mok;Yi Long Wu;Iveta Kudaba;Dariusz M. Kowalski

  • AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

    Pasi A. Jänne;James Chih-Hsin Yang;Dong Wan Kim;David Planchard

  • Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

    Ezra E W Cohen;Denis Soulières;Christophe Le Tourneau;Christophe Le Tourneau;Christophe Le Tourneau;José Dinis

  • Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

    Ken Kato;Byoung Chul Cho;Masanobu Takahashi;Morihito Okada

  • First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

    Ji-Youn Han;Keunchil Park;Sang-We Kim;Dae Ho Lee

  • Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer

    D. Ross Camidge;Hye Ryun Kim;Myung Ju Ahn;James Chih Hsin Yang

  • Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study

    Edward B. Garon;Matthew D. Hellmann;Naiyer A. Rizvi;Enric Carcereny

  • Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.

    Nayoung Kim;Nayoung Kim;Nayoung Kim;Hong Kwan Kim;Kyungjong Lee;Yourae Hong;Yourae Hong

  • Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).

    Alexander Drilon;Salvatore Siena;Sai Hong Ignatius Ou;Manish Patel

  • Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

    Daniel B. Costa;Alice T. Shaw;Sai-Hong I. Ou;Benjamin J. Solomon

  • Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

    Dong-Wan Kim;Dong-Wan Kim;Marcello Tiseo;Myung-Ju Ahn;Karen L Reckamp

  • Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.

    James Chih Hsin Yang;Myung Ju Ahn;Dong Wan Kim;Suresh S. Ramalingam

  • Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

    Naiyer A Rizvi;Byoung Chul Cho;Niels Reinmuth;Ki Hyeong Lee

  • Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations

    Alexander Drilon;Sai Hong Ignatius Ou;Byoung Chul Cho;Dong Wan Kim

  • Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial

    Jean Charles Soria;Yi Long Wu;Kazuhiko Nakagawa;Sang We Kim

  • Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer

    T.S. Mok;Y.-L. Wu;M.-J. Ahn;M.C. Garassino

Frequent Co-Authors

Keunchil Park
Keunchil Park The University of Texas MD Anderson Cancer Center
Jin Seok Ahn
Jin Seok Ahn Sungkyunkwan University
Se-Hoon Lee
Se-Hoon Lee Sungkyunkwan University
Dong-Wan Kim
Dong-Wan Kim Seoul National University Hospital
Byoung Chul Cho
Byoung Chul Cho Yonsei University
Jeeyun Lee
Jeeyun Lee Sungkyunkwan University
Jhingook Kim
Jhingook Kim Sungkyunkwan University
James Chih-Hsin Yang
James Chih-Hsin Yang National Taiwan University
Woong-Yang Park
Woong-Yang Park Samsung Medical Center
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca

External Links

Personal website of Myung-Ju Ahn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean following the traditional MD route. There are numerous online degree options that can prepare you for important roles within healthcare. Many students consider pursuing the cheapest mha online programs for a quick and affordable path to leadership positions in hospitals and clinics.

For nurses aiming to reach the highest levels of clinical practice, cheap dnp online programs offer a flexible way to obtain a Doctor of Nursing Practice degree while balancing work and study. Likewise, aspiring pharmacists can now attend online pharmacy schools, making it easier to advance without relocating or pausing their careers.

If you’re interested in the technology and data side of healthcare, consider pursuing a him bachelor's degree online. This field is rapidly growing and offers strong job prospects. With these diverse online pathways, students can find affordable, flexible options tailored to a variety of health-related careers.

Best Scientists Citing Myung-Ju Ahn

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 150

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 145

Caicun Zhou

Caicun Zhou

Tongji University

Publications: 133

James Chih-Hsin Yang

James Chih-Hsin Yang

National Taiwan University

Publications: 111

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 104

Alice T. Shaw

Alice T. Shaw

Harvard University

Publications: 104

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 102

Tony Mok

Tony Mok

Chinese University of Hong Kong

Publications: 102

Li Zhang

Li Zhang

Sun Yat-sen University

Publications: 97

Dong-Wan Kim

Dong-Wan Kim

Seoul National University Hospital

Publications: 96

Alexander Drilon

Alexander Drilon

Memorial Sloan Kettering Cancer Center

Publications: 93

Sai-Hong Ignatius Ou

Sai-Hong Ignatius Ou

University of California, Irvine

Publications: 89

Fabrice Barlesi

Fabrice Barlesi

Institut Gustave Roussy

Publications: 87

Kazuhiko Nakagawa

Kazuhiko Nakagawa

Kindai University

Publications: 86

Matthew D. Hellmann

Matthew D. Hellmann

Memorial Sloan Kettering Cancer Center

Publications: 84

Luis Paz-Ares

Luis Paz-Ares

Complutense University of Madrid

Publications: 79

Trending Scientists

Neil P. Dasgupta

Neil P. Dasgupta

University of Michigan–Ann Arbor

Ling Wang

Ling Wang

Tianjin University

Martha L. Slattery

Martha L. Slattery

University of Utah

John F. Curry

John F. Curry

Duke University

Marianne Vestergaard

Marianne Vestergaard

University of Copenhagen

Kumar Venkitanarayanan

Kumar Venkitanarayanan

University of Connecticut

Lucy S. Tompkins

Lucy S. Tompkins

Stanford University

Margaret E. Collinson

Margaret E. Collinson

Royal Holloway University of London

Cheol-Hee Kim

Cheol-Hee Kim

Chungnam National University

Alfonso Benito-Calvo

Alfonso Benito-Calvo

National Research Center on Human Evolution

Andrzej Stasiak

Andrzej Stasiak

University of Lausanne

Christoph Pfeifer

Christoph Pfeifer

BOKU University

Eleni Diamanti

Eleni Diamanti

Université Paris Cité

Kamal M.F. Itani

Kamal M.F. Itani

Boston University

C. Guillermo Bueno

C. Guillermo Bueno

Instituto Pirenaico de Ecología

Paulo A.F. Martins

Paulo A.F. Martins

Instituto Superior Técnico

Related Medicine Rankings & Guides

2026 Best Online Dual FNP/PMHNP Degree Programs

2026 Best Online Dual FNP/PMHNP Degree Programs
2026 Best Online Surgical Tech Certificate Programs

2026 Best Online Surgical Tech Certificate Programs
2026 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus
2026 Best Online Medical Assistant Associate Degree Programs

2026 Best Online Medical Assistant Associate Degree Programs
2026 Best Shortest Online DNP Programs

2026 Best Shortest Online DNP Programs
August 2026 Best Online Master’s of Science in Nursing Degree Programs

August 2026 Best Online Master’s of Science in Nursing Degree Programs
August 2026 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees

August 2026 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees
2026 Best Online Nursing Programs in Iowa – Accredited RN to BSN Programs

2026 Best Online Nursing Programs in Iowa – Accredited RN to BSN Programs
2026 Best PharmD Accelerated Degree Programs

2026 Best PharmD Accelerated Degree Programs
2026 Easiest RN-to-BSN Online Programs

2026 Easiest RN-to-BSN Online Programs
2026 Best Online MSN/MBA Dual Degree Programs

2026 Best Online MSN/MBA Dual Degree Programs
2026 Best Shortest Online Post-Master's FNP Certificate Programs

2026 Best Shortest Online Post-Master's FNP Certificate Programs
2026 Best Online Associate in Health Sciences

2026 Best Online Associate in Health Sciences
2026 Best RN to BSN Programs With No Clinicals

2026 Best RN to BSN Programs With No Clinicals
2026 Easiest Nurse Midwife Programs to Get Into

2026 Easiest Nurse Midwife Programs to Get Into
2026 Most Affordable Online DNP Programs

2026 Most Affordable Online DNP Programs
2026 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

2026 Most Affordable Online Direct Entry MSN Programs for Non-Nurses
2026 Fastest Online Graduate Certificate Nurse Midwifery Programs

2026 Fastest Online Graduate Certificate Nurse Midwifery Programs
2026 Best One-Year Online PMHNP Programs

2026 Best One-Year Online PMHNP Programs
2026 Fastest Online MSN in Forensic Nursing Programs

2026 Fastest Online MSN in Forensic Nursing Programs
2026 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus

Recently Published Articles

2026 Biochemistry Degree Programs You Can Start Without Meeting All Requirements

2026 Biochemistry Degree Programs You Can Start Without Meeting All Requirements
2026 Fastest Online Master's Programs in Clinical Mental Health Counseling

2026 Fastest Online Master's Programs in Clinical Mental Health Counseling
2026 Fastest Online Master's Degree Programs in Analytics

2026 Fastest Online Master's Degree Programs in Analytics
2026 Best Online Crime Analysis Degree Programs

2026 Best Online Crime Analysis Degree Programs
2026 How to Become an Ethical Hacker: Education, Salary, and Job Outlook

2026 How to Become an Ethical Hacker: Education, Salary, and Job Outlook
2026 Admission Requirements for Family Nurse Practitioner Degree Programs

2026 Admission Requirements for Family Nurse Practitioner Degree Programs
2026 Nonprofit Scholarships and Grants for ABA Graduate Students

2026 Nonprofit Scholarships and Grants for ABA Graduate Students
2026 Best Accelerated Psychology Degree Programs Online

2026 Best Accelerated Psychology Degree Programs Online
2026 Best Online CAHME-Accredited MHA Programs

2026 Best Online CAHME-Accredited MHA Programs
2026 How Much Do Medical Assistant Programs & Certifications Cost?

2026 How Much Do Medical Assistant Programs & Certifications Cost?
2026 One-Year Online Spanish Master's Degree Programs: Accelerated Options, Costs & Outcomes

2026 One-Year Online Spanish Master's Degree Programs: Accelerated Options, Costs & Outcomes
2026 Best Accredited Online Criminal Justice Bachelor's Degree Programs

2026 Best Accredited Online Criminal Justice Bachelor's Degree Programs
2026 Different Types of Homeland Security Degrees and Their Salaries

2026 Different Types of Homeland Security Degrees and Their Salaries
2026 How to Become a Marriage and Family Therapist in Texas: Requirements & Certification

2026 How to Become a Marriage and Family Therapist in Texas: Requirements & Certification
2026 How to Become a Medicolegal Death Investigator: Education, Salary, and Job Outlook

2026 How to Become a Medicolegal Death Investigator: Education, Salary, and Job Outlook
2026 How to Become a Substance Abuse Counselor in Mississippi

2026 How to Become a Substance Abuse Counselor in Mississippi
August 2026 Fastest Executive MHA (Master’s in Healthcare Administration) Programs

August 2026 Fastest Executive MHA (Master’s in Healthcare Administration) Programs
2026 Best 6 Month Certificate Programs That Pay Well

2026 Best 6 Month Certificate Programs That Pay Well
2026 Military-Friendly Online Software Engineering Bachelor's Degree Programs

2026 Military-Friendly Online Software Engineering Bachelor's Degree Programs
2026 Best Online Theology Degree Programs

2026 Best Online Theology Degree Programs
2026 Cheapest and Shortest Online Music Business Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Music Business Degree Programs That Pay Well: Cost, Duration, and Salary Outlook